statistiche ricercatore

Continente	#
NA - Nord America	562
AS - Asia	415
EU - Europa	344
Continente sconosciuto - Info sul continente non disponibili	87
SA - Sud America	85
AF - Africa	24
Totale	1.517

Nazione	#
US - Stati Uniti d'America	541
CN - Cina	177
IE - Irlanda	86
SG - Singapore	85
BR - Brasile	67
IT - Italia	60
DE - Germania	55
HK - Hong Kong	52
RU - Federazione Russa	42
VN - Vietnam	36
FI - Finlandia	32
IN - India	24
ZA - Sudafrica	20
GB - Regno Unito	19
CA - Canada	15
FR - Francia	15
CZ - Repubblica Ceca	8
ID - Indonesia	7
AR - Argentina	5
BD - Bangladesh	5
EC - Ecuador	5
SE - Svezia	5
ES - Italia	4
PK - Pakistan	4
PL - Polonia	4
TR - Turchia	4
VE - Venezuela	4
BE - Belgio	3
CH - Svizzera	3
CO - Colombia	3
IQ - Iraq	3
JP - Giappone	3
GE - Georgia	2
GT - Guatemala	2
MX - Messico	2
NL - Olanda	2
TW - Taiwan	2
UZ - Uzbekistan	2
AO - Angola	1
AT - Austria	1
AZ - Azerbaigian	1
BY - Bielorussia	1
CR - Costa Rica	1
EG - Egitto	1
HN - Honduras	1
IL - Israele	1
IM - Isola di Man	1
KE - Kenya	1
KZ - Kazakistan	1
LT - Lituania	1
MY - Malesia	1
NA - Namibia	1
NP - Nepal	1
OM - Oman	1
PH - Filippine	1
PT - Portogallo	1
PY - Paraguay	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
Totale	1.430

Nome	#
Gut Microbiota Analysis in Postoperative Lynch Syndrome Patients	150
A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors	144
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK	131
New and old hot drug targets in tuberculosis	119
Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity.	117
New antitubercular prodrugs with novel mechanisms of action	116
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053	114
Pyrazole and imidazo[1,2-b]pyrazole derivatives as new potential anti-tuberculosis agents.	112
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug	112
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase	109
Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.	109
Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity.	96
Identification of a New FtsZ Inhibitor by Virtual Screening, Mechanistic Insights, and Structure-Activity Relationship Analyses	88
Totale	1.517

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	59	0	0	2	0	2	0	0	2	2	3	10	38
2022/2023	183	20	20	3	4	12	19	0	4	96	0	5	0
2023/2024	128	17	18	0	4	6	21	4	20	1	4	25	8
2024/2025	272	9	21	6	4	9	28	16	18	60	10	35	56
2025/2026	583	56	35	84	90	66	24	85	37	46	29	19	12
2026/2027	34	15	19	0	0	0	0	0	0	0	0	0	0
Totale													1.517